Covid-19 Inhibitor
Catalog No. F17-901C
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
F17-901C-50 | 5 mg | $90 | |
F17-901C-250 | 25 mg | $300 | |
F17-901C-BULK | BULK | Contact Us |
Overview:
A potent and selective, ATP-competitive inhibitor of mTOR kinase, Ki = 1.4 nM (1). Inhibits growth and proliferation of various breast cancer cell lines and human endothelial cells (2).
References:
1. AC Hsieh et al. Nature 2012 485:55 2. Y Gokmen-Polar et al. Breast Cancer Res. Treat. 2012 136:673
Molecular Formula:
C15H15N7O
Appearance:
Off-white powder
Molecular Weight:
309.3
Alias:
3-(2-amino-5-benzaxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; MLN-0128
Specific Activity:
mTOR Inhibitor
Storage and Stability:
Store desiccated as supplied at -20°C for up to 2 years. Store solutions at -20°C for up to 3 months.
There are no related publications available for this product.
Acute Respiratory Distress Syndrome , Cardiovascular Disease, Cellular Stress, COVID19, Infectious Diseases , Inflammation, severe acute respiratory syndrome coronavirus 2 , Virology
STAY CONNECTED
Fax: 1-604-232-4601